Rabacfosadine
Catalog No. A21217
Rabacfosadine (GS-9219), a novel prodrug of the nucleotide analogue PMEG, is designed as a cytotoxic agent that preferentially targets lymphoid cells.
Catalog Num | A21217 |
---|---|
M. Wt | 526.53 |
Formula | C21H35N8O6P |
Purity | >98% |
Storage | at -20 °C 3 years (powder form); at -20 °C 6 months (Solution base) |
CAS No. | 859209-74-8 |
Synonyms | GS-9219, GS9219, GS 9219; VDC-1101, VDC1101, VDC 1101 |
SMILES | CCOC([[email protected]](C)NP(N[[email protected]@H](C)C(OCC)=O)(COCCN1C=NC2=C(NC3CC3)N=C(N)N=C12)=O)=O |
Rabacfosadine (GS-9219), a novel prodrug of the nucleotide analogue PMEG, is designed as a cytotoxic agent that preferentially targets lymphoid cells.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.99 mL | 94.96 mL | 189.92 mL |
0.5 mM | 3.8 mL | 18.99 mL | 37.98 mL |
1 mM | 1.9 mL | 9.5 mL | 18.99 mL |
5 mM | 0.38 mL | 1.9 mL | 3.8 mL |
*The above data is based on the productmolecular weight 526.53. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.